SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is facing intense investor scrutiny as a significant rise in AI infrastructure spending and substantial legal costs triggered an earnings miss and lukewarm future guidance. The community is sharply divided, with some investors panic-selling over margin compression and heavy capital expenditure, while others characterize the dip as a long-term buying opportunity in a dominant digital advertising company.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is trending as investors digest a strong earnings report that exceeded expectations, particularly in Azure cloud growth, while simultaneously easing concerns regarding AI infrastructure spending. The community is actively discussing the stock's role as a potential safe haven in a volatile market, with many traders debating the impact of the company's capital expenditure strategy on the broader tech sector.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as investors react to the company's regulatory expansion into the UAE and Saudi Arabia, while active community debate centers on the contrast between international growth and perceived FDA delays. The stock is experiencing significant volatility, with retail investors closely monitoring upcoming quarterly results and speculating on potential institutional partnerships to counter high short interest.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

The iShares 20+ Year Treasury Bond ETF is trending as rising geopolitical tensions in the Middle East drive oil prices higher and fuel investor fears of persistent inflation. Community sentiment is currently split, with many traders analyzing the inverse relationship between surging yields and equity market stability while discussing whether this environment signals an impending recession or a long-term bottom for bonds.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood shares are under significant pressure as investors rotate out of growth names amid broader market volatility and uncertainty heading into the upcoming earnings report. The community remains deeply divided, with some highlighting strong fundamental growth and new business lines as a reason to buy the dip, while others express frustration over recent price declines and concerns about market manipulation.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is facing intense scrutiny regarding its aggressive AI infrastructure spending ahead of key earnings, as investors debate whether AWS growth can justify current capital expenditures. The community is actively discussing the stock's recent volatility and mixed sentiment, with many focusing on whether the company's long-term cloud and satellite expansion plans will ultimately provide the necessary returns to reward shareholders.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is trending due to heightened speculation surrounding a potential buyout and the company's aggressive pipeline expansion into treatment-resistant schizophrenia. While community sentiment remains intensely bullish on Briumvi's market share growth, investors are actively debating the timing of a premium acquisition as the stock maintains a strong technical performance despite intermittent volatility.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

SPY is experiencing extreme volatility and heavy selling pressure as traders grapple with geopolitical tensions in Iran, rising 30-year bond yields, and conflicting reactions to the recent FOMC decision. The community is sharply divided between those bracing for a deeper market correction driven by sector rotation and those hunting for tactical bounces fueled by mega-cap tech earnings.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune is seeing significant volatility as investors weigh the potential for a third FDA resubmission against lingering skepticism regarding trial design and clinical data quality. Community sentiment remains polarized, with many traders speculating on a regulatory lifeline or potential short-squeeze, while others cite recurring concerns over trial design and the company's long-term capital requirements.

Chipotle Mexican Grill, Inc. engages in the business of developing and operating restaurants that serve a relevant menu of burritos, burrito bowls, quesadillas, tacos, and salads made using fresh, high-quality ingredients. The company was founded by Steve Ells in 1993 and is headquartered in Newport Beach, CA.

Chipotle Mexican Grill

Chipotle shares are surging as the company beat Q2 earnings expectations and raised its full-year outlook, driven by menu innovation, loyalty rewards, and AI-powered operational improvements. The community is actively debating the stock's long-term growth potential and recent upward momentum, with many users highlighting management's 'Recipe for Growth' strategy as a key catalyst for optimism.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Amarin's Q2 Earnings Beat Estimates, Revenues Fall Short

AMRN surpasses Q2 earnings estimates despite lower revenues, as cost cuts, rising demand and global partner-driven growth shape its ongoing transformation.

Dr. Reddy's Q1 Earnings and Revenues Miss Estimates, Stock Down

RDY's fiscal Q1 earnings and revenues miss estimates as weaker North America generics sales hurt results, sending shares down 9%.

GSK Lands FDA Approval for Nuvalent-Acquired Jideytro for NSCLC

GSK secures early FDA approval for Jideytro, its first lung cancer therapy, backed by strong ARROS-1 data, and strengthens its precision oncology portfolio.

AGIO Shares Sink Nearly 7% After Scrapping the Tebapivat SCD Program

Agios drops after ending tebapivat development for SCD as phase II data confirmed PK activation but failed to show sufficient clinical differentiation.

Here's Why You Should Add Savara Stock to Your Portfolio Now

SVRA advances Molbreevi with positive long-term phase III data, an FDA review on track and expanded patent protection supporting its commercial outlook.

Acadia Gets FDA's Fast Track Tag for Alzheimer's Disease Candidate

 ACAD wins FDA's Fast Track status for remlifanserin in Alzheimer's disease psychosis as its phase II data readout approaches and phase III enrollment advances.

DYN Stock Rises 19.2% in 3 Months: What's Driving the Rally?

Dyne gains momentum as FDA priority review for its lead DMD therapy and progress in its DM1 program strengthen confidence in its pipeline.

ZNTL Stock Rises 28% in 3 Months: What's Driving the Rally?

Zentalis shares climb 28% over the past three months as optimism builds around azenosertib's ovarian cancer program.

GSK Discontinues Development of Camlipixant for Refractory Chronic Cough

GSK drops camlipixant's refractory chronic cough program after mixed phase III results, but the drug remains in a phase IIb study for irritable bowel syndrome.

Here's Why You Should Add INKT Stock to Your Portfolio Now

MiNK advances agenT-797 across respiratory, oncology and immune disease studies while expanding its next-generation engineered iNKT pipeline.

$AMRN Q2 &#39;26 Earnings Results &amp; Recap

Amarin Corporation expects continued growth in international markets, maintenance of VASCEPAs U.S. market share, an improved OPEX profile, positive cash flow generation, and U.S. volumes to remain consistent throughout FY 2026.

Stocktwits

Amarin Corp - ADR

 Q2 '26 Earnings Results & Recap

Amarin Corporation expects continued growth in international markets, maintenance of VASCEPAs U.S. market share, an improved OPEX profile, positive cash flow generation, and U.S. volumes to remain consistent throughout FY 2026.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

$AMRN Q2 '26 Earnings Results & Recap

Amarin Corporation expects continued growth in international markets, maintenance of VASCEPAs U.S. market share, an improved OPEX profile, positive cash flow generation, and U.S. volumes to remain consistent throughout FY 2026.

Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Extremely Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

AMRNAmarin Corp - ADR

Fundamentals

Latest AMRN News